Cornell Tech's Deborah Estrin earns IEEE Internet Award

Deborah Estrin, professor of computer science at Cornell Tech and professor of public health at Weill Cornell Medicine, has won a 2017 IEEE Internet Award for for contributions to internet technology.

Intestinal fungi may aid in relief of inflammatory disease

Fungi that live in a healthy gut may be as important for good health as beneficial intestinal bacteria, according to new research conducted at Weill Cornell Medicine.

Chemical exacerbates common bacterial infection, study says

A naturally produced chemical exacerbates infection by a common bacteria, rendering the infection significantly harder for the body to clear, according to new Cornell cross-campus research.

'Global City Sampling Day' launches Weill antimicrobial study

Spanning six continents, 32 countries and 54 cities, more than 12,000 samples of DNA, RNA and microbes from surfaces in subways, buses, airports and other well-traveled public meeting spaces were collected June 21.

Cornell to launch new Master of Public Health program

Starting in the fall 2017 semester, Cornell University will offer a Master of Public Health degree with a focus on epidemiology, infectious disease, food systems and sustainability.

Icon, innovator, dean feted at eighth annual SHA awards dinner

Nearly 600 School of Hotel Administration students, faculty and supporters honored two industry legends and the school’s outgoing dean June 7 at the eighth annual Cornell Hospitality Icon and Innovator Awards.

Campus charisma emerges through Cornell Tech students

Entering a new age in education, Dan Huttenlocher, the dean and vice provost of Cornell Tech, explained the new school's charm and allure as it begins to bloom in New York City.

Gift establishes Tisch Professorship at Jacobs Institute

A gift from Andrew ’71 and Ann Tisch to Cornell University and the American Technion Society has created an endowed professorship at the Joan & Irwin Jacobs Technion-Cornell Institute at Cornell Tech.

Early assessment, drug switch improves cancer treatment

Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response: new research from Weill Cornell Medicine.